Retatrutide (LY3437943) is a triple agonist peptide targeting glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor. This research compound has shown potential in glucose control and weight management studies.
Our pharmaceutical grade Retatrutide is supplied in lyophilized form with purity exceeding 99.8%. The product is carefully packaged to ensure stability and should be stored at -20°C or below for optimal preservation.
For researchers looking to buy semaglutide UK alternatives or related peptides, we offer custom formulation services with various dosage options including 2mg, 5mg, 10mg, 15mg, 20mg, 30mg and 50mg vials. Private labeling and custom packaging solutions are available for qualified research institutions.
Note: This product is for research use only, not for human consumption. All transactions are subject to verification of intended research purpose.